Results 21 to 30 of about 57,061 (258)
Increased Risk of Metabolic Syndrome in Patients with Vitiligo
Balkan Medical Journal, 2017 The risk of developing metabolic syndrome is increased in patients with vitiligo. The poor clinical features of vitiligo, such as active, extended and segmental vitiligo with an increased duration of time, are independent predictors for developing ...
Hatice Ataş, Müzeyyen Gönül
doaj +1 more source
Chemical vitiligo: A subset of vitiligo
Indian Journal of Dermatology, 2020 Chemical leucoderma, an under-diagnosed common condition often mimicking idiopathic vitiligo, represents an acquired depigmentation induced by repeated exposure to specific chemical compounds in subjects with genetic susceptibility to vitiligo. This has been increasing rapidly in incidence in recent decades in developing countries like India. The term '
openaire +4 more sources
Nederlands tijdschrift voor geneeskunde, 1997 Vitiligo is a disorder in which, owing to disappearance of melanocytes in the skin, sharply delimited, symmetrically arranged white patches develop. The condition occurs in 1-2% of the population, mostly between the ages of 10 and 30 years, and as often in males as in females. The course is usually progressive with periods of stability.
Njoo, M.D., Westerhof, W.
openaire +5 more sources
A clinico-epidemiological study on childhood vitiligo
Indian Journal of Paediatric Dermatology, 2016 Introduction: Vitiligo is a disorder of melanocytes which may have a significant effect on the psyche of a patient. Aims: To study the clinical profile of the patients with childhood vitiligo and see the association of vitiligo with other autoimmune ...
Neerja Puri
doaj +1 more source
Serum thyroid hormone antibodies are frequent in patients with polyglandular autoimmune syndrome type 3, particularly in those who require thyroxine treatment [PDF]
, 2017 Polyglandular autoimmune syndrome (PAS) type 3 consists of autoimmune thyroid disease (AITD) coexisting with ≥1 non-thyroidal autoimmune disease (NTAID) other than Addison’s disease and hypoparathyroidism. We evaluated the prevalence and repertoire of
Benvenga, Salvatore +8 more
core +1 more source
Indian Journal of Dermatology, 2023 Introduction: Vitiligo is a multifactorial disorder, most often explained by the autoimmune hypothesis. The objective of this study is to measure the levels of cytokines IL-6, TNF-α, and IFN-γ in the blood and skin (lesional and uninvolved) of vitiligo ...
Abhishek De +4 more
doaj +1 more source
Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. [PDF]
PLoS ONE, 2012 BACKGROUND: Vitiligo is characterized by the death of melanocytes in the skin. This is associated with the presence of T cell infiltrates in the lesional borders.
Richard Yu +13 more
doaj +1 more source
High Level of Tumor Necrosis Alpha and Serum Interferon Gamma as Risk Factors for Progression of Vitiligo Disease [PDF]
, 2018 Vitiligo is an autoimmune disease that causes melanocyte of dysfunction. Cytokines played an important role in the pathogenesis of vitiligo. Interferon-gamma and TNF-µ were cytokines that induce apoptosis of melanocyte cell.
Indira, I. E. (IGAA) +3 more
core +1 more source
Clinical Features of Vitiligo and Social Impact on Quality of Life
Dermatology Practical & Conceptual, 2023 Vitiligo is the most common cause of depigmentation and its estimated worldwide prevalence ranges from 0.5% to 2%. The disease is characterized by the development of white macules resulting from a loss of epidermal melanocytes.
Seneschal Julien
doaj +1 more source
Evaluation of S100B serum level as a biomarker of disease activity in vitiligo patients [PDF]
International Journal of Medical Arts, 2019 Background: Vitiligo is a depigmenting disorder characterized by the appearance of circumscribed white macules in the skin. The aetiology of vitiligo is not clear, and although various hypotheses have been proposed.
radwa abd El-Halim +3 more
doaj +1 more source